Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The RESPOND Outcomes Study - A Study in the RESPOND Consortium (RESPOND: International Cohort Consortium of Infectious Diseases)

NCT04090151 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT04090151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04090151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The RESPOND Outcomes Study - A Study in the RESPOND Consortium (RESPOND: International Cohort Consortium of Infectious Diseases)
Lead sponsor
Rigshospitalet, Denmark
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2017
Completion date
December 31, 2025
Enrollment
37,853 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

hiv